CD56+ cells induce steroid resistance in B cells exposed to IL-15

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 7110-7115

  Xu, Qing ^a   Goleva, Elena ^a   Ou, Liang Shiou ^a,c   Li, Ling Bo ^a   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD56 ANTIGEN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 15; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 4; STEROID;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CORTICOSTEROID THERAPY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; INFLAMMATION; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; STEROID THERAPY; T LYMPHOCYTE;

EID: 2442718975     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.7110     Document Type: Article

References (49)

1. Kam, J. C., S. J. Szefler, W. Surs, E. R. Sher, and D. Y. Leung. 1993. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151:3460.
2. Spahn, J. D., S. J. Szefler, W. Surs, D. E. Doherty, S. R. Nimmagadda, and D. Y. Leung. 1996. A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J. Immunol. 157:2654.
3. Hill, M. R., R. D. Stith, and R. E. McCallum. 1988. Human recombinant IL-1 alters glucocorticoid receptor function in Reuber hepatoma cells. J. Immunol. 141:1522.
4. Pariante, C. M., B. D. Pearce, T. L. Pisell, C. I. Sanchez, C. Po, C. Su, and A. H. Miller. 1999. The proinflammatory cytokine, interleukin-1α, reduces glucocorticoid receptor translocation and function. Endocrinology 140:4359.
5. Goleva, E., K. O. Kisich, and D. Y. Leung. 2002. A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J. Immunol. 169:5934.
6. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, K. Ohbo, M. Nakamura, and T. Takeshita. 1996. The interleukin-2 receptor γ-chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14:179.
7. Asao, H., C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K. Sugamura. 2001. Cutting edge: the common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167:1.
8. Bulfone-Paus, S., H. Durkop, R. Paus, H. Krause, T. Pohl, and A. Onu. 1997. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 9:507.
9. Trentin, L., R. Zambello, M. Facco, R. Sancetta, C. Agostini, and G. Semenzato. 1997. Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk. Lymphoma 27:35.
10. De Jong, J. L., N. L. Famer, M. B. Widmer, J. G. Giri, and P. M. Sondel. 1996. Interaction of IL-15 with the shared IL-2 receptor β and γc subunits: the IL-15/β/γc. receptor-ligand complex is less stable than the IL-2/β/γc receptor-ligand complex. J. Immunol. 156:1339.
11. Giri, J. G., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, and D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor. EMBO J. 14:3654.
12. Bamford, R. N., A. J. Grant, J. D. Burton, C. Peters, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940.
13. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
14. Losy, J., A. Niezgoda, and J. Zaremba, 2002. IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathol. 40:151.
15. Leung, D. Y., and J. W. Bloom. 2003. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 111:3.
16. Antakly, T., D. O'Donnell, and E. B. Thompson. 1990. Immunocytochemical localization of the glucocorticoid receptor in steroid-sensitive and -resistant human leukemic cells. Cancer Res. 50:1337.
17. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, M. Nakamura, and T. Takeshita. 1995. The common γ-chain for multiple cytokine receptors. Adv. Immunol. 59:225.
18. Stevens, A. C., J. Matthews, P. Andres, V. Baffis, X. X. Zheng, D. W. Chae, J. Smith, T. B. Strom, and W. Maslinski. 1997. Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor β-chain. Am. J. Physiol. 272:G1201.
19. Bulfone-Pau, S. S., E. Bulanova, T. Pohl, V. Budagian, H. Durkop, R. Ruckert, U. Kunzendorf, R. Paus, and H. Krause. 1999. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain. FASEB J. 13:1575.
20. Bulanova, E., V. Budagian, T. Pohl, H. Krause, H. Durkop, R. Paus, and S. Bulfone-Paus. 2001. The IL-15R α chain signals through association with Syk in human B cells. J. Immunol. 167:6292.
21. Quinn, L. S., K. L. Haugk, and K. H. Grabstein. 1995. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 136:3669.
22. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578.
23. Han, G. W., K. Iwatsuki, M. Inoue, T. Matsui, A. Nishibu, H. Akiba, and F. Kaneko. 1999. Interleukin-15 is not a constitutive cytokine in the epidermis, but is inducible in culture or inflammatory conditions. Acta Derm. Venereol. 79:37.
24. Walsh, G. M., D. W. Sexton, and M. G. Blaylock. 2003. Corticosteroids, eosinophils and bronchial epithelia) cells: new insights into the resolution of inflammation in asthma. J. Endocrinol. 178:37.
25. Armitage, R. J., B. M. Macduff, J. Eisenman, R. Paxton, and K. H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483.
26. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.
27. Hausmann, M. J., B. Rogachev, M. Weiler, C. Chaimovitz, and A. Douvdevani. 2000. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int. 57:476.
28. Badolato, R., A. N. Ponzi, M. Millesimo, L. D. Notarangelo, and T. Musso. 1997. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90:2804.
29. Pelletier, M., C. Ratthe, and D. Girard. 2002. Mechanisms involved in interleukin-15-induced suppression of human neutrophil apoptosis: role of the anti-apoptotic Mcl-1 protein and several kinases including Janus kinase-2, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases-1/2. FEBS Lett 532:164.
30. Ong, P. Y., Q. A. Hamid, J. B. Travers, I. Strickland, M. Al Kerithy, M. Boguniewicz, and D. Y. Leung. 2002. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J. Immunol. 168:505.
31. Ishimitsu, R., H. Nishimura, T. Yajima, T. Watase, H. Kawauchi, and Y. Yoshikai. 2001. Overexpression of IL-15 in vivo enhances Tc1 response, which inhibits allergic inflammation in a murine model of asthma. J. Immunol. 166:1991.
32. Dunne, J., S. Lynch, C. O'Farrelly, S. Todryk, J. E. Hegarty, C. Feighery, and D. G. Doherty. 2001. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J. Immunol. 167:3129.
33. Deniz, G., M. Akdis, E. Aktas, K. Blaser, and C. A. Akdis. 2002. Human NK1 and NK2 subsets determined by purification of IFN-γ-secreting and IFN-γ-non-secreting NK cells. Eur. J. Immunol. 32:879.
34. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166:6012.
35. Leite-De-Moraes, M. C., A. Hameg, M. Pacilio, Y. Koezuka, M. Taniguchi, L. Van Kaer, E. Schneider, M. Dy, and A. Herbelin. 2001. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 166:945.
36. Korsgren, M. 2002. NK cells and asthma. Curr. Pharm. Des. 8:1871.
37. Zhong, M., A. Tai, and I. Yamamoto. 2001. IgE production is involved in butyrate-enhanced NK cell activity in vivo. Chin. Med. Sci. J. 16:76.
38. Souzdaltseva, T. V., T. V. Makarova, and N. N. Vechkanova. 2000. NK cells and IgE level in peripheral blood in aspirin-induced and allergic bronchial asthma. Russ. J. Immunol. 5:315.
39. Kawamura, T., R. Koka, A. Ma, and V. Kumar. 2003. Differential roles for IL-15R α-chain in NK cell development and Ly-49 induction. J. Immunol. 171:5085.
40. Voss, S. D., P. M. Sondel, and R. J. Robb. 1992. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R γ chain with the IL-2R β chain in functional intermediate-affinity IL-2R. J. Exp. Med. 176:531.
41. Baume, D. M., M. J. Robertson, H. Levine, T. J. Manley, P. W. Schow, and J. Ritz. 1992. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 22:1.
42. Xia, X., H. K. Lee, S. C. Clark, and Y. S. Choi. 1989. Recombinant interleukin (IL) 2-induced human B cell differentiation is mediated by autocrine IL-6. Eur. J. Immunol. 19:2275.
43. Rieckmann, P., F. D'Alessandro, R. P. Nordan, A. S. Fauci, and J. H. Kehrl. 1991. IL-6 and tumor necrosis factor-α: autocrine and paracrine cytokines involved in B cell function. J. Immunol. 146:3462.
44. Lemanske, R. F., Jr. 2003. Viruses and asthma: inception, exacerbation and possible prevention. J. Pediatr. 142:S3.
45. Lemanske, R. F., Jr., and W. W. Busse. 2003. Asthma. J. Allergy Clin. Immunol. 111:S502.
46. Cohen, L., and M. Castro, 2003. The role of viral respiratory infections in the pathogenesis and exacerbation of asthma. Semin. Respir. Infect. 18:3.
47. Sigurs, N. 2002. A cohort of children hospitalized with acute RSV bronchiolitis: impact on later respiratory disease. Paediatr. Respir. Rev. 3:177.
48. French, A. R., and W. M. Yokoyama. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15:45.
49. Van Dommelen, S. L., H. A. Tabarias, M. J. Smyth, and M. A. Degli-Esposti. 2003. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77:1877.